Skip to main content

Table 1 Demographics and tumor characteristics

From: A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer

Characteristics (n = 74)

No. of patients (%)

Age, median years (range)

61 (21-79)

Primary site

  Ovary

69 (93)

  Peritoneal

2 (3)

  Fallopian tube

3 (4)

Original stage

  Ic

5 (7)

  IIb

1 (1)

  IIc

5 (7)

  IIIa

4 (5)

  IIIb

5 (7)

  IIIc

45 (61)

  IV

8 (11)

  Unknown

1 (1)

Tumor grade

  Well differentiate

11 (15)

  Moderate well differentiate

21 (28)

  Poorly differentiate/undifferentiate

36 (49)

  Unknown

6 (8)

Histologic type

  Serous

60 (81)

  Mucinous

2 (3)

  Clear cell

2 (3)

  Endometroid

5 (7)

  Undifferentiate

1 (1)

  Other

4 (5)

Response to firs line therapy

  Complete response (CR)

38 (51)

  Partial response (PR)

8 (11)

  Stable disease (SD)

2 (3)

  Non-evaluated disease (NED)

26 (35)

Time from end of first line chemotherapy to relapse

  Median months (range)

15.7 (6-80.9)

  Relapse between 6 to 12 months

26 (35.1%)

  Relapse >12 months

48 (64.9%)